STAT 405 BIOSTATISTICS (Fall 2016) Handout 9 Number Needed to Treat, Number Needed to Harm, and Attributable Risk
|
|
- Mitchell Wilkinson
- 6 years ago
- Views:
Transcription
1 STAT 405 BIOSTATISTICS (Fall 06) The Absolute Risk Reduction (ARR) is the difference between the event rate in the experimental group and the event rate in the control group. In other words, this is the change in absolute risk brought about by an experimental intervention. The Number Needed to Treat (NNT) is the reciprocal of the ARR. EXAMPLE: An analgesic agent is given to 00 people, and 70 have their pain relieved within two hours. In contrast, the administration of a placebo tablet containing no active drug leads to pain relief in only 0 out of 00 people. Source: Questions:. What is the ARR?. What is the NNT? Interpretation: Two people must be given the analgesic for one of them to obtain effective pain relief. EXAMPLE: Consider the use of a thrombolytic agent after myocardial infarction. Say that 0,000 men have no thrombolytic treatment after a heart attack, and,000 die within six weeks. In contrast, of 0,000 men given a thrombolytic agent, the number dying within six weeks is reduced to 800. Source: Questions:. What is the ARR?. What is the NNT? Interpretation: Fifty people must be given the thrombolytic therapy after a heart attack to prevent one of them from dying within six weeks who would have died had they not been given thrombolysis.
2 STAT 405 BIOSTATISTICS (Fall 06) These interpretations lead to an alternative definition of NNT: The Number Needed to Treat (NNT) can also be defined as the number of persons who must be treated for a given period to achieve an event (treatment) or to prevent an event (prophylaxis). CALCULATING NNTs AND CONFIDENCE INTERVALS The NNT can be calculated from the simple formula: NNT = = ARR (Proportion who benefit from treatment - Proportion who benefit from control) NNT = = ARR (Proportion of adverse outcomes w/o trt - Proportion of adverse outcomes w/trt) Questions:. What does an NNT of imply?. If a treatment works well, do you expect to see a large NNT? Explain. We have already discussed the calculation of NNT for two examples. However, it should be noted that this point estimate is likely to change if we took another sample. Therefore, we should also report a confidence interval for NNT.
3 STAT 405 BIOSTATISTICS (Fall 06) The most commonly used method for constructing a confidence interval for NNT involves inverting and exchanging the confidence limits for the ARR. Confidence Interval for the ARR Let pˆ = the proportion who benefit in the treatment group and pˆ = the proportion who benefit in the control group (n and n are the group sample sizes, respectively). ARR ± z α pˆ ( - pˆ ) pˆ ( - pˆ ) + n n This is the same the confidence interval for (pp pp ) covered in introductory statistics courses. Confidence Interval for the NNT Simply invert and exchange the confidence limits for the ARR. EXAMPLE: Consider the example in which an analgesic agent is given to 00 people, and 70 have their pain relieved within two hours. In contrast, the administration of a placebo tablet containing no active drug leads to pain relief in only 0 out of 00 people. Find a 95% confidence interval for ARR: Find a 95% confidence interval for NNT: 3
4 STAT 405 BIOSTATISTICS (Fall 06) Using R to Find the Confidence Interval for the ARR and NNT You can use the prop.test function in R as follows. > num_relief <- c(70,0) > num_group <- c(00,00) > prop.test(num_relief,num_group,correct=false) Can omit this to employ the continuity correction -sample test for equality of proportions without continuity correction data: num_relief out of num_group X-squared = , df =, p-value =.89e- alternative hypothesis: two.sided 95 percent confidence interval: sample estimates: prop prop To find the enpdoints for a confidence interval for the NNT, you can invert and exchange the confidence limits for the ARR. Another Method for Finding a Confidence Interval for the ARR and NNT Ralf Bender, an epidemiologist, argues that the method used above to find a confidence interval for the ARR often leads to unreliable confidence limits. He argues that instead of using this method, one should use Wilson s score method for calculating the confidence interval for ARR. You can read more in his paper titled Improving the calculation of confidence intervals for the number needed to treat. He has made a SAS program available which calculates the ARR, NNT, and confidence intervals using both the unreliable method and his proposed method. The program is available in the file Bender_CIs.sas. To use this program, you need only enter your data as follows: e = 70; /* Number who benefit in experimental group */ n = 00; /* Sample size of experimental group */ e = 0; /* Number who benefit in control group */ n = 00; /* Sample size of control group */ The rest of the program should remain untouched! 4
5 STAT 405 BIOSTATISTICS (Fall 06) Output: General Comments on the NNT and the Confidence Interval:. The Wilson method has been shown to have a higher coverage rate than the asymptotic method.. The asymptotic method is most unreliable with very small sample sizes or with a very low absolute risk reduction (ARR). 3. Any estimated NNT should be accompanied by its confidence interval, and it is good practice to state which calculation method was used for the interval. 4. The only time it is appropriate to compare NNTs is if we have NNTs for different interventions for the same condition with the same outcome of interest. 5
6 STAT 405 BIOSTATISTICS (Fall 06) Number Needed to Harm (NNH) For adverse effects, we can calculate a number needed to harm (NNH). NNH = = ARR (Prop. adversely affected bytreatment - Prop. adversely affected by control) This can be regarded as the number of persons that must be given a treatment in order to cause harm to one patient that would not have otherwise been harmed. EXAMPLE: An example of a drug that was removed from the market due to a low NNH is encainide. A 99 study in the New England Journal of Medicine found proarrhythmic effects of encainide and flecainide were more likely in the antiarrhythmic group than in the placebo group. Data from the study are presented below: Treatment Total # of Subjects Death/cardiac arrest placebo flecainide or encainide Source: Questions:. Find the NNH.. Interpret this quantity. 3. Find a 95% confidence interval for the NNH. 6
7 STAT 405 BIOSTATISTICS (Fall 06) Attributable Risk (AR) From page 646 of your text: In some cases, a risk factor may have a large RR. However, if the risk factor is relatively rare, only a small proportion of cases may be attributable to this risk factor. Conversely, if a risk factor is common, then even a moderate RR may translate to a large number of cases attributable to the risk factor. The concept of attributable risk is useful in these circumstances. EXAMPLE: Cancer (Example 3.4 from your text) To see the intuition behind attributable risk, consider the following data table. A group of 0,000 current smoking women and 40,000 never-smoking women ages were followed for 5 years to see if they developed lung cancer. Lung Cancer No Lung Cancer Totals Smoker 50 9,950 0,000 Nonsmoker 0 39,990 40,000 Totals 60 49,940 50,000 One proposed formula for computing the relative risk is as follows: A AR =, where A + B + C A = Number of smokers who develop lung cancer, due to their smoking habit B = Number of smokers who develop lung cancer, but not due to their smoking habit C = Number of nonsmokers who develop lung cancer For these data, AR = This is called the attributable risk (AR), which is usually expressed a percent. We can interpret this quantity by saying that of lung cancer cases are attributable to smoking. 7
8 STAT 405 BIOSTATISTICS (Fall 06) We can also express the AR as follows: p(rr - ) AR = p(rr ) +, where p = the probability that a person has the risk factor RR = the relative risk for a disease for persons with the risk factor as compared to those without the risk factor Lung Cancer No Lung Cancer Totals Smoker 50 9,950 0,000 Nonsmoker 0 39,990 40,000 Totals 60 49,940 50,000 Using this formula, the AR could also be computed as follows: Confidence Interval for AR (Equation 3., pg. 648) 00% eecc eecc + ee cc, 00% + ee cc Here (cc, cc ) is the interval obtained from yy ± zz αα RRRR bb + dd, where yy = ln AAAA RRRR aann ccnn 00 AAAA Note: There are very nice derivations of the standard errors (variances) of the RR, OR, and AR used in the confidence intervals presented in the text. These derivations use the delta method which is covered in mathematical statistics (STAT 450/460). You should definitely examine the derivation of the var(rr), var(or), and var(ar) in the book if you have this background!. 8
9 STAT 405 BIOSTATISTICS (Fall 06) R function for inference on the AR The following R function can be used to compute the AR and its confidence interval. AR = function(a,b,c,d,alpha=.05) { RR <- (a/(a+b))/(c/(c+d)) p <- (a+b)/(a+b+c+d) logrr <- log(rr) SElogRR <- sqrt((b/(a*(a+b))) + (d/(c*(c+d)))) za = qnorm( - (alpha/)) AR = 00*(RR - )*p/((rr - )*p + ) y = log(ar/(00 - AR)) marerr <- za*(rr/abs(rr-))*selogrr c = y - marerr c = y + marerr LCL <- 00*exp(c)/(+exp(c)) UCL <- 00*exp(c)/(+exp(c)) cat("\n") cat(paste("estimated AR =",format(ar,dig=4))) cat("\n") cat(paste("ci for AR = (",format(lcl,dig=4),",",format(ucl,dig=4),")")) cat("\n\n") } Consider the data from the previous example. Lung Cancer No Lung Cancer Totals Smoker 50 9,950 0,000 Nonsmoker 0 39,990 40,000 Totals 60 49,940 50,000 Call the function as follows to find the attributable risk (AR) of lung cancer associated with smoking (and the CI). > AR(50,9950,0,39990) Estimated AR = 79.7 CI for AR = ( 65.04, ) 9
Sections 10.7 and 10.9
Sections 10.7 and 10.9 Timothy Hanson Department of Statistics, University of South Carolina Stat 205: Elementary Statistics for the Biological and Life Sciences 1 / 24 10.7 confidence interval for p 1
More informationBiostatistics 2 - Correlation and Risk
BROUGHT TO YOU BY Biostatistics 2 - Correlation and Risk Developed by Pfizer January 2018 This learning module is intended for UK healthcare professionals only. PP-GEP-GBR-0957 Date of preparation Jan
More informationReview Statistics review 11: Assessing risk Viv Bewick 1, Liz Cheek 1 and Jonathan Ball 2
Available online http://ccforum.com/content/8/4/87 Review Statistics review 11: Assessing risk Viv Bewick 1, Liz Cheek 1 and Jonathan Ball 1 Senior Lecturer, School of Computing, Mathematical and Information
More informationGLOSSARY OF GENERAL TERMS
GLOSSARY OF GENERAL TERMS Absolute risk reduction Absolute risk reduction (ARR) is the difference between the event rate in the control group (CER) and the event rate in the treated group (EER). ARR =
More informationWelcome to this third module in a three-part series focused on epidemiologic measures of association and impact.
Welcome to this third module in a three-part series focused on epidemiologic measures of association and impact. 1 This three-part series focuses on the estimation of the association between exposures
More informationMeasuring association in contingency tables
Measuring association in contingency tables Patrick Breheny April 8 Patrick Breheny Introduction to Biostatistics (171:161) 1/25 Hypothesis tests and confidence intervals Fisher s exact test and the χ
More informationProportions, risk ratios and odds ratios
Applied Biostatistics Proportions, risk ratios and odds ratios Martin Bland Professor of Health Statistics University of York http://www-users.york.ac.uk/~mb55/ Risk difference Difference between proportions:
More informationMaking comparisons. Previous sessions looked at how to describe a single group of subjects However, we are often interested in comparing two groups
Making comparisons Previous sessions looked at how to describe a single group of subjects However, we are often interested in comparing two groups Data can be interpreted using the following fundamental
More informationDo the sample size assumptions for a trial. addressing the following question: Among couples with unexplained infertility does
Exercise 4 Do the sample size assumptions for a trial addressing the following question: Among couples with unexplained infertility does a program of up to three IVF cycles compared with up to three FSH
More informationA point estimate is a single value that has been calculated from sample data to estimate the unknown population parameter. s Sample Standard Deviation
7.1 Margins of Error and Estimates What is estimation? A point estimate is a single value that has been calculated from sample data to estimate the unknown population parameter. Population Parameter Sample
More informationW e have previously described the disease impact
606 THEORY AND METHODS Impact numbers: measures of risk factor impact on the whole population from case-control and cohort studies R F Heller, A J Dobson, J Attia, J Page... See end of article for authors
More informationUSING STATCRUNCH TO CONSTRUCT CONFIDENCE INTERVALS and CALCULATE SAMPLE SIZE
USING STATCRUNCH TO CONSTRUCT CONFIDENCE INTERVALS and CALCULATE SAMPLE SIZE Using StatCrunch for confidence intervals (CI s) is super easy. As you can see in the assignments, I cover 9.2 before 9.1 because
More informationMeasuring association in contingency tables
Measuring association in contingency tables Patrick Breheny April 3 Patrick Breheny University of Iowa Introduction to Biostatistics (BIOS 4120) 1 / 28 Hypothesis tests and confidence intervals Fisher
More informationA point estimate is a single value that has been calculated from sample data to estimate the unknown population parameter. s Sample Standard Deviation
7.1 Margins of Error and Estimates What is estimation? A point estimate is a single value that has been calculated from sample data to estimate the unknown population parameter. Population Parameter Sample
More informationConsider the following hypothetical
Nurse Educator Nurse Educator Vol. 32, No. 1, pp. 16-20 Copyright! 2007 Wolters Kluwer Health Lippincott Williams & Wilkins How to Read, Interpret, and Understand Evidence-Based Literature Statistics Dorette
More informationInstructions for doing two-sample t-test in Excel
Instructions for doing two-sample t-test in Excel (1) If you do not see Data Analysis in the menu, this means you need to use Add-ins and make sure that the box in front of Analysis ToolPak is checked.
More informationHow Causal Heterogeneity Can Influence Statistical Significance in Clinical Trials
How Causal Heterogeneity Can Influence Statistical Significance in Clinical Trials Milo Schield, W. M. Keck Statistical Literacy Project. Minneapolis, MN. Abstract: Finding that an association is statistically
More informationLogistic Regression Predicting the Chances of Coronary Heart Disease. Multivariate Solutions
Logistic Regression Predicting the Chances of Coronary Heart Disease Multivariate Solutions What is Logistic Regression? Logistic regression in a nutshell: Logistic regression is used for prediction of
More informationPPH Domain: Learning Objectives Synopsis: probability frequency Prevalence Incidence Relative risk - Question 1
Learning Resource: Measuring Disease Frequency and Association: Self Directed Tutorial PPH Domain: Dr. David King, School of Population Health, d.king@som.uq.edu.au Learning Objectives: Define, interpret
More informationTwo-sample Categorical data: Measuring association
Two-sample Categorical data: Measuring association Patrick Breheny October 27 Patrick Breheny University of Iowa Biostatistical Methods I (BIOS 5710) 1 / 40 Introduction Study designs leading to contingency
More informationCritical Appraisal of Evidence
Critical Appraisal of Evidence A Focus on Intervention/Treatment Studies Bernadette Mazurek Melnyk, PhD, CPNP/PMHNP, FNAP, FAAN Associate Vice President for Health Promotion University Chief Wellness Officer
More informationTORCH: Salmeterol and Fluticasone Propionate and Survival in COPD
TORCH: and Propionate and Survival in COPD April 19, 2007 Justin Lee Pharmacy Resident University Health Network Outline Overview of COPD Pathophysiology Pharmacological Treatment Overview of the TORCH
More informationPsy201 Module 3 Study and Assignment Guide. Using Excel to Calculate Descriptive and Inferential Statistics
Psy201 Module 3 Study and Assignment Guide Using Excel to Calculate Descriptive and Inferential Statistics What is Excel? Excel is a spreadsheet program that allows one to enter numerical values or data
More informationContingency Tables Summer 2017 Summer Institutes 187
Contingency Tables 87 Overview ) Types of Variables ) Comparing () Categorical Variables Contingency (two-way) tables Tests 3) x Tables Sampling designs Testing for association Estimation of effects Paired
More informationProviding High Value Cost-Conscious Care:
Providing High Value Cost-Conscious Care: Biostatistical Concepts You Need to Know 2012-2013 Presentation #5 0f 10 http://hvc.acponline.org/ Learning Objectives Understand that a working knowledge of basic
More informationAP STATISTICS 2009 SCORING GUIDELINES (Form B)
AP STATISTICS 2009 SCORING GUIDELINES (Form B) Question 6 Intent of Question The primary goals of this investigative task were to assess students ability to (1) evaluate whether a double-blind randomized
More informationMEASURING THE SIZE OF A TREATMENT EFFECT: RELATIVE RISK REDUCTION, ABSOLUTE RISK REDUCTION, AND NUMBER NEEDED TO TREAT
MEASURING THE SIZE OF A TREATMENT EFFECT: RELATIVE RISK REDUCTION, ABSOLUTE RISK REDUCTION, AND NUMBER NEEDED TO TREAT Hussein Hollands, MD, MS (epid) Peter J. Kertes, MD, CM, FRCS(C) 72 The purpose of
More informationLearning Objectives 9/9/2013. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency
Conflicts of Interest I have no conflict of interest to disclose Biostatistics Kevin M. Sowinski, Pharm.D., FCCP Last-Chance Ambulatory Care Webinar Thursday, September 5, 2013 Learning Objectives For
More information9/4/2013. Decision Errors. Hypothesis Testing. Conflicts of Interest. Descriptive statistics: Numerical methods Measures of Central Tendency
Conflicts of Interest I have no conflict of interest to disclose Biostatistics Kevin M. Sowinski, Pharm.D., FCCP Pharmacotherapy Webinar Review Course Tuesday, September 3, 2013 Descriptive statistics:
More informationINTERNAL VALIDITY, BIAS AND CONFOUNDING
OCW Epidemiology and Biostatistics, 2010 J. Forrester, PhD Tufts University School of Medicine October 6, 2010 INTERNAL VALIDITY, BIAS AND CONFOUNDING Learning objectives for this session: 1) Understand
More informationACR OA Guideline Development Process Knee and Hip
ACR OA Guideline Development Process Knee and Hip 1. Literature searching frame work Literature searches were developed based on the scenarios. A comprehensive search strategy was used to guide the process
More informationBiostatistics 2 nd year Comprehensive Examination. Due: May 31 st, 2013 by 5pm. Instructions:
Biostatistics 2 nd year Comprehensive Examination Due: May 31 st, 2013 by 5pm. Instructions: 1. The exam is divided into two parts. There are 6 questions in section I and 2 questions in section II. 2.
More informationAcute myocardial infarction. Cardiovascular disorders. main/0202_new 02/03/06. Search date August 2004 Nicholas Danchin and Eric Durand
main/0202_new 02/03/06 Acute myocardial infarction Search date August 2004 Nicholas Danchin and Eric Durand QUESTIONS Which treatments improve outcomes in acute myocardial infarction?...4 Which treatments
More informationyou-try-it-02.xlsx Step-by-Step Guide ver. 8/26/2009
you-try-it-02.xlsx Step-by-Step Guide ver. 8/26/2009 Abstract This document provides step-by-step instructions for the Excel workbook you-try-it-02.xlsx (Excel 2007). The worksheets contain data for practice
More informationAnalysis of single gene effects 1. Quantitative analysis of single gene effects. Gregory Carey, Barbara J. Bowers, Jeanne M.
Analysis of single gene effects 1 Quantitative analysis of single gene effects Gregory Carey, Barbara J. Bowers, Jeanne M. Wehner From the Department of Psychology (GC, JMW) and Institute for Behavioral
More informationDatabase of treatment effects user guide
Database of treatment effects user guide The following is a manual for how to use the database of treatment effects. The first section explains how the spreadsheet works. The second section explains some
More informationJournal Club Critical Appraisal Worksheets. Dr David Walbridge
Journal Club Critical Appraisal Worksheets Dr David Walbridge The Four Part Question The purpose of a structured EBM question is: To be directly relevant to the clinical situation or problem To express
More informationGender Analysis. Week 3
Gender Analysis Week 3 1 Objectives 1. Understand how to practically conduct gender analysis 2. Learn and apply measures of frequency and association 2 100 75 50 25 0 Measures of Disease Frequency and
More informationWORKSHEET: Etiology/Harm
Updated 9/10/2013 Name: WORKSHEET: Etiology/Harm Citation: McGregor SE, Courneya KS, Kopciuk KA, Tosevski C, Friedenreich CM. Case control study of lifetime alcohol intake and prostate cancer risk. Cancer
More informationCHAPTER III METHODOLOGY
24 CHAPTER III METHODOLOGY This chapter presents the methodology of the study. There are three main sub-titles explained; research design, data collection, and data analysis. 3.1. Research Design The study
More informationIntroduction to Biostatistics Math 4310-Biol6317. August 23, 2011
Introduction to Biostatistics Math 4310-Biol6317 August 23, 2011 Syllabus Website: www.math.uh.edu/~bgb/courses Office hours: Tu 11:30-12:20pm, We 2-2:50pm Q.: Can everyone make it to at least one day?
More informationCommon Statistical Issues in Biomedical Research
Common Statistical Issues in Biomedical Research Howard Cabral, Ph.D., M.P.H. Boston University CTSI Boston University School of Public Health Department of Biostatistics May 15, 2013 1 Overview of Basic
More informationSimple Sensitivity Analyses for Matched Samples Thomas E. Love, Ph.D. ASA Course Atlanta Georgia https://goo.
Goal of a Formal Sensitivity Analysis To replace a general qualitative statement that applies in all observational studies the association we observe between treatment and outcome does not imply causation
More informationA Case Study: Two-sample categorical data
A Case Study: Two-sample categorical data Patrick Breheny January 31 Patrick Breheny BST 701: Bayesian Modeling in Biostatistics 1/43 Introduction Model specification Continuous vs. mixture priors Choice
More information- Decide on an estimator for the parameter. - Calculate distribution of estimator; usually involves unknown parameter
General Confidence Intervals 1 - Decide on an estimator for the parameter - Calculate distribution of estimator; usually involves unknown parameter - Convert a confidence statement about where the estimate
More informationHowever, if instead, CHD risk is plotted on a doubling scale (as in slide 2) then there is a
Slides 1 and 2: These two illustrative slides (based on notionaldata) were used in my presentation to Dr Godlee at our meeting on 2 December 2013 to show that, if the risk of coronary disease (CHD) is
More informationEpidemiologic Study Designs. (RCTs)
Epidemiologic Study Designs Epidemiologic Study Designs Experimental (RCTs) Observational Analytical Descriptive Case-Control Cohort + cross-sectional & ecologic Epidemiologic Study Designs Descriptive
More informationTHERAPEUTIC REASONING
THERAPEUTIC REASONING Christopher A. Klipstein (based on material originally prepared by Drs. Arthur Evans and John Perry) Objectives: 1) Learn how to answer the question: What do you do with the post
More informationChapter 12: Introduction to Analysis of Variance
Chapter 12: Introduction to Analysis of Variance of Variance Chapter 12 presents the general logic and basic formulas for the hypothesis testing procedure known as analysis of variance (ANOVA). The purpose
More informationGarvan Ins)tute Biosta)s)cal Workshop 7/5/2015. Tuan V. Nguyen. Garvan Ins)tute of Medical Research Sydney, Australia
Garvan Ins)tute Biosta)s)cal Workshop 7/5/2015 Tuan V. Nguyen Tuan V. Nguyen Garvan Ins)tute of Medical Research Sydney, Australia What I am going to cover... Randomized controlled trial (RCT) Concept
More informationCohort studies. Training Course in Sexual and Reproductive Health Research Geneva Nguyen Thi My Huong, MD PhD WHO/RHR/SIS
Cohort studies Training Course in Sexual and Reproductive Health Research Geneva 2012 Nguyen Thi My Huong, MD PhD WHO/RHR/SIS OUTLINE Overview Definitions Study design Basic measures Advantages and disadvantages
More informationUnderstanding Statistics for Research Staff!
Statistics for Dummies? Understanding Statistics for Research Staff! Those of us who DO the research, but not the statistics. Rachel Enriquez, RN PhD Epidemiologist Why do we do Clinical Research? Epidemiology
More informationCritical Appraisal of Evidence A Focus on Intervention/Treatment Studies
Critical Appraisal of Evidence A Focus on Intervention/Treatment Studies Bernadette Mazurek Melnyk, PhD, CPNP/PMHNP, FAANP, FAAN Associate Vice President for Health Promotion University Chief Wellness
More informationADENIYI MOFOLUWAKE MPH APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL
ADENIYI MOFOLUWAKE MPH 510 - APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL 4 2013 Question 1: What makes the first study a case-control study? The first case study is a case-control study because
More informationLesson: A Ten Minute Course in Epidemiology
Lesson: A Ten Minute Course in Epidemiology This lesson investigates whether childhood circumcision reduces the risk of acquiring genital herpes in men. 1. To open the data we click on File>Example Data
More informationCARDIOVASCULAR HEALTH LIVING A HEART HEALTHY LIFE. Matt Handley MD Group Health Physicians
CARDIOVASCULAR HEALTH LIVING A HEART HEALTHY LIFE Matt Handley MD Group Health Physicians WILLIE SUTTON Add together your risk of dying from breast cancer and colon cancer (women), or prostate cancer and
More informationCancer Incidence Predictions (Finnish Experience)
Cancer Incidence Predictions (Finnish Experience) Tadeusz Dyba Joint Research Center EPAAC Workshop, January 22-23 2014, Ispra Rational for making cancer incidence predictions Administrative: to plan the
More informationTutorial #7A: Latent Class Growth Model (# seizures)
Tutorial #7A: Latent Class Growth Model (# seizures) 2.50 Class 3: Unstable (N = 6) Cluster modal 1 2 3 Mean proportional change from baseline 2.00 1.50 1.00 Class 1: No change (N = 36) 0.50 Class 2: Improved
More informationEssential Skills for Evidence-based Practice: Statistics for Therapy Questions
Essential Skills for Evidence-based Practice: Statistics for Therapy Questions Jeanne Grace Corresponding author: J. Grace E-mail: Jeanne_Grace@urmc.rochester.edu Jeanne Grace RN PhD Emeritus Clinical
More informationThe Cardiac Arrythmia Suppression Trial
The Cardiac Arrythmia Suppression Trial 1 The Cardiac Arrythmia Suppression Trial Background and significance Methods Statistical Analysis Results Discussion Summary on Therapy 2 Background and significance
More informationNew Math: Taking on Overdiagnosis Waste and Harm Flipped Classroom: Pre-work
New Math: Taking on Overdiagnosis Waste and Harm Flipped Classroom: Pre-work IHI Forum, Session C24 Faculty: Dr. James Leo, Helen Macfie Session Objectives Understand the difference between absolute and
More informationLAB ASSIGNMENT 4 INFERENCES FOR NUMERICAL DATA. Comparison of Cancer Survival*
LAB ASSIGNMENT 4 1 INFERENCES FOR NUMERICAL DATA In this lab assignment, you will analyze the data from a study to compare survival times of patients of both genders with different primary cancers. First,
More informationInference About Magnitudes of Effects
invited commentary International Journal of Sports Physiology and Performance, 2008, 3, 547-557 2008 Human Kinetics, Inc. Inference About Magnitudes of Effects Richard J. Barker and Matthew R. Schofield
More informationQuantifying the Benefits and Harms of Interventions: Relative vs. Absolute Risk
JOURNAL CLUB LECTURE SERIES: Quantifying the Benefits and Harms of Interventions: Relative vs. Absolute Risk Tuesday, May 12 th, 2015 Anil N. Makam, MD MAS Oanh K. Nguyen, MD MAS Division of General Internal
More informationMeta- Analysis of Varenicline Use and Treatment- Emergent Cardiovascular Serious Adverse Events
Meta- Analysis of Varenicline Use and Treatment- Emergent Cardiovascular Serious Adverse Events Judith J. Prochaska, PhD, MPH Associate Professor of Medicine Stanford PrevenDon Research Center Stanford
More informationCohort studies. Training course in research methodology and research protocol development Geneva Nguyen Thi My Huong, MD PhD WHO/RHR/SIS
Cohort studies Training course in research methodology and research protocol development Geneva 2018 Nguyen Thi My Huong, MD PhD WHO/RHR/SIS OUTLINE Overview Definitions Study design Basic measures Advantages
More informationSubsequent management and therapies
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Subsequent management and therapies Marco Valgimigli, MD, PhD University of Ferrara ITALY
More informationOutline. What is Evidence-Based Practice? EVIDENCE-BASED PRACTICE. What EBP is Not:
Evidence Based Practice Primer Outline Evidence Based Practice (EBP) EBP overview and process Formulating clinical questions (PICO) Searching for EB answers Trial design Critical appraisal Assessing the
More informationSTAT 111 SEC 006 PRACTICE EXAM 1: SPRING 2007
STAT 111 SEC 006 PRACTICE EXAM 1: SPRING 2007 1. You want to know the opinions of American schoolteachers about establishing a national test for high school graduation. You obtain a list of the members
More informationNicotine replacement therapy to improve quit rates
Nicotine replacement therapy to improve quit rates Matrix Insight, in collaboration with Imperial College London, Kings College London and Bazian Ltd, were commissioned by Health England to undertake a
More informationThe Association Design and a Continuous Phenotype
PSYC 5102: Association Design & Continuous Phenotypes (4/4/07) 1 The Association Design and a Continuous Phenotype The purpose of this note is to demonstrate how to perform a population-based association
More informationTHERAPY WORKSHEET: page 1 of 2 adapted from Sackett 1996
THERAPY WORKSHEET: page 1 of 2 adapted from Sackett 1996 Citation: Are the results of this single preventive or therapeutic trial valid? Was the assignment of patients to treatments randomised? -and was
More informationSheila Barron Statistics Outreach Center 2/8/2011
Sheila Barron Statistics Outreach Center 2/8/2011 What is Power? When conducting a research study using a statistical hypothesis test, power is the probability of getting statistical significance when
More informationMethods of Calculating Deaths Attributable to Obesity
American Journal of Epidemiology Copyright 2004 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 160, No. 4 Printed in U.S.A. DOI: 10.1093/aje/kwh222 Methods of Calculating
More informationConflicts of Interest: None. Aspirin, primary prevention and USPSTF. Primary prevention of ASCVD is important
Aspirin, primary prevention and USPSTF Presented by: Craig Williams, PharmD., BCPS., FNLA; February 2017 Conflicts of Interest: None Primary prevention of ASCVD is important Myocardial Infarction Incidence
More informationToday: Binomial response variable with an explanatory variable on an ordinal (rank) scale.
Model Based Statistics in Biology. Part V. The Generalized Linear Model. Single Explanatory Variable on an Ordinal Scale ReCap. Part I (Chapters 1,2,3,4), Part II (Ch 5, 6, 7) ReCap Part III (Ch 9, 10,
More informationPresentation Outline. Introduction to Biomedical Research Designs. EBM: A Practical Definition. Grade the Evidence (Example McMaster Grading System)
Presentation Outline Introduction to Biomedical Research Designs Sean D. Sullivan, R.Ph., PhD Professor of Pharmacy, Public Health and Medicine University of Washington Why a course in Biomedical Research
More informationAnalyzing Discrete Data
Analyzing Discrete Data Kwang Woo Ahn, PhD Sponsored by the Clinical and Translational Science Institute (CTSI) and the Department of Population Health / Division of Biostatistics Speaker disclosure In
More informationOne-Way Independent ANOVA
One-Way Independent ANOVA Analysis of Variance (ANOVA) is a common and robust statistical test that you can use to compare the mean scores collected from different conditions or groups in an experiment.
More information5.3: Associations in Categorical Variables
5.3: Associations in Categorical Variables Now we will consider how to use probability to determine if two categorical variables are associated. Conditional Probabilities Consider the next example, where
More informationLec 02: Estimation & Hypothesis Testing in Animal Ecology
Lec 02: Estimation & Hypothesis Testing in Animal Ecology Parameter Estimation from Samples Samples We typically observe systems incompletely, i.e., we sample according to a designed protocol. We then
More informationSTATISTICS INFORMED DECISIONS USING DATA
STATISTICS INFORMED DECISIONS USING DATA Fifth Edition Chapter 4 Describing the Relation between Two Variables 4.1 Scatter Diagrams and Correlation Learning Objectives 1. Draw and interpret scatter diagrams
More informationRAG Rating Indicator Values
Technical Guide RAG Rating Indicator Values Introduction This document sets out Public Health England s standard approach to the use of RAG ratings for indicator values in relation to comparator or benchmark
More informationCHAPTER 3 DATA ANALYSIS: DESCRIBING DATA
Data Analysis: Describing Data CHAPTER 3 DATA ANALYSIS: DESCRIBING DATA In the analysis process, the researcher tries to evaluate the data collected both from written documents and from other sources such
More informationBayesian Confidence Intervals for Means and Variances of Lognormal and Bivariate Lognormal Distributions
Bayesian Confidence Intervals for Means and Variances of Lognormal and Bivariate Lognormal Distributions J. Harvey a,b, & A.J. van der Merwe b a Centre for Statistical Consultation Department of Statistics
More informationDAILY SMOKERS - AVERAGE NUMBER OF CIGARETTES SMOKED DAILY KEY MESSAGES
DAILY SMOKERS - AVERAGE KEY MESSAGES On average, daily smokers in Peel smoke 12 cigarettes per day (2011/2012) and this has remained stable over time. Daily smokers in Ontario smoke slightly more per day
More informationSection G. Comparing Means between More than Two Independent Populations
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationPredictors of Cigarette Smoking Behavior Among Military University Students in Taiwan. Wang, Kwua-Yun; Yang, Chia-Chen
The Henderson Repository is a free resource of the Honor Society of Nursing, Sigma Theta Tau International. It is dedicated to the dissemination of nursing research, researchrelated, and evidence-based
More informationA Brief Introduction to Bayesian Statistics
A Brief Introduction to Statistics David Kaplan Department of Educational Psychology Methods for Social Policy Research and, Washington, DC 2017 1 / 37 The Reverend Thomas Bayes, 1701 1761 2 / 37 Pierre-Simon
More informationOnline Introduction to Statistics
APPENDIX Online Introduction to Statistics CHOOSING THE CORRECT ANALYSIS To analyze statistical data correctly, you must choose the correct statistical test. The test you should use when you have interval
More informationMultivariate dose-response meta-analysis: an update on glst
Multivariate dose-response meta-analysis: an update on glst Nicola Orsini Unit of Biostatistics Unit of Nutritional Epidemiology Institute of Environmental Medicine Karolinska Institutet http://www.imm.ki.se/biostatistics/
More informationSESSION 3 11 AM 12:30 PM
SESSION 3 11 AM 12:30 PM for the Primary Prevention of Cardiovascular Disease: A Personalized Approach SPEAKER Samia Mora MD, MHS Presenter Disclosure Information The following relationships exist related
More informationTo: Olten, June 5 th, 2015 / mr1.0. Dear colleagues
To: Prof. N. Rodondi, MD (Member of AGLA, Inselspital Bern), PD Dr. med. Erik von Elm (IUMSP, Centre Hospitalier Universitaire Vaudois, Lausanne) Prof. Dr. med. Christoph Meier (Stadtspital Triemli, Zürich)
More informationPubHlth Introductory Biostatistics Practice Test I (Without Unit 3 Questions)
1 PubHlth 540 - Introductory Biostatistics Practice Test I (Without Unit 3 Questions) 1. (10 points) In the Honolulu Heart Study, Systolic Blood Pressure was tabulated for 100 Subjects including 37 Smokers
More informationEvidence-based medicine and guidelines: development and implementation into practice
Evidence-based medicine and guidelines: development and implementation into practice PD Dr D. Aujesky, MSc MER Médecin-adjoint Service de Médecine Interne CHUV 1 Goals To discuss the basics of evidence-based
More informationINTRODUCTION TO ECONOMETRICS (EC212)
INTRODUCTION TO ECONOMETRICS (EC212) Course duration: 54 hours lecture and class time (Over three weeks) LSE Teaching Department: Department of Economics Lead Faculty (session two): Dr Taisuke Otsu and
More informationStatistical Significance, Effect Size, and Practical Significance Eva Lawrence Guilford College October, 2017
Statistical Significance, Effect Size, and Practical Significance Eva Lawrence Guilford College October, 2017 Definitions Descriptive statistics: Statistical analyses used to describe characteristics of
More informationReflection Questions for Math 58B
Reflection Questions for Math 58B Johanna Hardin Spring 2017 Chapter 1, Section 1 binomial probabilities 1. What is a p-value? 2. What is the difference between a one- and two-sided hypothesis? 3. What
More informationMeasures of Association
Measures of Association Lakkana Thaikruea M.D., M.S., Ph.D. Community Medicine Department, Faculty of Medicine, Chiang Mai University, Thailand Introduction One of epidemiological studies goal is to determine
More informationTREATING THE MANY TO BENEFIT THE FEW : USING EXAMPLES FROM HEALTHCARE TO MAKE STATISTICS EXCITING AND RELEVANT
TREATING THE MANY TO BENEFIT THE FEW : USING EXAMPLES FROM HEALTHCARE TO MAKE STATISTICS EXCITING AND RELEVANT Taiwo Amoo, Department of Business Management, Murray Koppelman School of Business Brooklyn
More information